Boston Private Bank & Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

Boston Private Bank & Trust’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$408K	Sell	3,905 -750	-16%	-$76K	0.02%	317
2014 Q4	$452K	Hold	4,655	–	–	0.02%	309
2014 Q3	$364K	Sell	4,655 -2,000	-30%	-$129K	0.02%	327
2014 Q2	$420K	Hold	6,655	–	–	0.02%	313
2014 Q1	$447K	Buy	+6,655	New	+$515K	0.02%	305
2013 Q3	–	Sell	-1,100	Closed	-$34K	–	981
2013 Q2	$34K	Buy	+1,100	New	+$29.3K	﹤0.01%	595

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boston Private Bank & Trust's ALNY Position: Q1 2015 in Review

Boston Private Bank & Trust reduced its Alnylam Pharmaceuticals (ALNY) stake by 16% in Q1 2015, selling an estimated $76K and leaving 3,905 shares worth $408K. The position accounts for 0.02% of the portfolio, ranked #317.

Boston Private Bank & Trust first reported a position in ALNY in Q2 2013 and has held it in 6 quarters since. The position peaked at $452K in Q4 2014. 238 funds tracked by Wall St. Rank hold ALNY as of Q1 2015.

Boston Private Bank & Trust held 3,905 shares of Alnylam Pharmaceuticals worth $408K as of Q1 2015.
Boston Private Bank & Trust sold 750 Alnylam Pharmaceuticals shares in Q1 2015, an estimated $76K.
Alnylam Pharmaceuticals made up 0.02% of Boston Private Bank & Trust's portfolio in Q1 2015, its #317 holding.
Boston Private Bank & Trust first reported a position in Alnylam Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
Boston Private Bank & Trust's Alnylam Pharmaceuticals position peaked at $452K in Q4 2014.
238 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.